Your Trusted Source for Life Sciences Data
Discover emerging life science companies, uncover qualified leads, and identify the right partners faster. By combining expert human curation with AI-driven intelligence, our platform delivers the insights you need to accelerate business development, licensing, and investment decisions with confidence.
Unique data sourcing process
leading to an exclusive data set
Over 1,070,000 regularly
updated clinical trials
69,000 companies with over
380,000 management contact details
Over 42,000 Biotech, Pharma and Medtech
assets available for licensing
Investor Database including
direct contact details
License agreements with payment
structures and original contract
BIOTECHGATE DIGITAL PARTNERING
Virtual business development & licensing event
Join five days of digital partnering, workshops and networking sessions. Establish new global connections thanks to pre-arranged one-on-one Zoom meetings.
Solutions by industry
Biotechgate is a versatile information source
catering to the entire life science industry.
What our clients say
Latest industry news
Taiwan Biotech Delegation Showcases Regional Innovation in CDMO, Cell Therapy, and Biologics at BioJapan 2026
06 Oct 2026
Read moreFapon Showcases High-Performance IVD Raw Materials at JACLaS EXPO 2026
06 Oct 2026
Read moreAurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
06 Oct 2026
Read moreUpcoming Conferences
06October2026
08October2026
CPHI Milan 2026
Milan, ItalyCPHI Milan 2026 is the world’s largest pharmaceutical trade fair, that will bringing the global pharma community together at Fiera Milano from October 06–08, 2026. In this 35th year of innovation, the CPHI Worldwide Milan 2026 will have over 62,000 visitors, and 2,400 exhibitors, from 166+ countries.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more 07October2026
08October2026
26th Annual Biotech in Europe Forum
Basel, SwitzerlandReturning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more 07October2026
09October2026
BioJapan
Yokohama, JapanBioJapan is Asia's premier bio-industry partnering event, comprising an Exhibition, Seminars, and Partnering. This year marks the 40th Anniversary since the first edition held in 1986, making BioJapan the world’s longest-running biotech exhibition. Along with its two co-located shows —Regenerative Medicine JAPAN, which accelerates R&D and commercialization in regenerative medicine, and healthTECH JAPAN, focusing on health management, diagnostics, and therapeutics through the integration of digital technology and life sciences — BioJapan continues to drive innovation and collaboration in the industry.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more 20October2026
20October2026
AusBiotech Invest
Queensland, AustraliaAusBiotech Invest is a core pillar of Australia’s Biggest Week in Biotech, a curated capital convening designed to strengthen the investment and capital environment around Australian life sciences.
More than a company showcase or investor-matching exercise, this AusBiotech Invest event will on the Gold Coast will bring together active investors, capital partners and a specially selected high potential companies to explore investment opportunities, market insights, syndication pathways and the broader conditions required to fund and scale high-potential Australian innovation. The program is being shaped through ongoing engagement with investors and capital partners to ensure it delivers meaningful opportunities for discussion, connection and investment consideration.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more